All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Opinion: Statin Use May Pose Greater Diabetes Risk Than FDA Acknowledges

By

Eric J. Topol

2d ago· 2 min readenOpinion

Summary

This opinion piece argues that the widespread use of statins for cholesterol reduction may lead to a significant increase in Type 2 diabetes cases. The author notes that the FDA recently updated statin labels to include warnings about diabetes and memory loss risks, though the agency described the risk as "small." The article contends that the diabetes risk is more substantial than acknowledged and questions the over-prescription of these medications.

Source

Twitter / XOpinion: Statin Use May Pose Greater Diabetes Risk Than FDA Acknowledgesnytimes.com

Key quotes

· 3 pulled
We're overdosing on cholesterol-lowering statins, and the consequence could be a sharp increase in the incidence of Type 2 diabetes.
The announcement said the risk was 'small' and should not materially affect the use of these medications.
But the magnitude of the problem for diabetes becomes much more apparent.
Snippet from the RSS feed
Statins are the popular choice for lowering cholesterol, but could result in a sharp increase in the incidence of Type 2 diabetes.

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.